Laurie E. Gaspar

Active 1990–2025

94
Papers
32,742
Citations
80
h-index
94
i10-index

Citations

Citations per year for Laurie E. Gaspar1959: 1 citations1991: 1 citations1992: 2 citations1993: 4 citations1994: 7 citations1995: 2 citations1996: 9 citations1997: 10 citations1998: 10 citations1999: 22 citations2000: 27 citations2001: 28 citations2002: 48 citations2003: 54 citations2004: 57 citations2005: 85 citations2006: 93 citations2007: 98 citations2008: 118 citations2009: 124 citations2010: 200 citations2011: 193 citations2012: 197 citations2013: 232 citations2014: 247 citations2015: 225 citations2016: 238 citations2017: 178 citations2018: 228 citations2019: 835 citations2020: 1,055 citations2021: 891 citations2022: 663 citations2023: 468 citations2024: 759 citations2025: 289 citations2026: 7 citations1960–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,378 citing papers, 28.6% of this breakdownChina: 698 citing papers, 8.4% of this breakdownCanada: 539 citing papers, 6.5% of this breakdownGermany: 494 citing papers, 5.9% of this breakdownItaly: 478 citing papers, 5.7% of this breakdownNetherlands: 379 citing papers, 4.6% of this breakdownUnited Kingdom: 332 citing papers, 4% of this breakdownFrance: 322 citing papers, 3.9% of this breakdownJapan: 306 citing papers, 3.7% of this breakdownSwitzerland: 285 citing papers, 3.4% of this breakdownSpain: 235 citing papers, 2.8% of this breakdownAustralia: 191 citing papers, 2.3% of this breakdown
0%28.6%Other 20.2%

Fields

  • Medicine86.6%
  • Biochemistry, Genetics and Molecular Biology5.5%
  • Physics and Astronomy4.6%
  • Neuroscience0.8%
  • Engineering0.8%
  • Immunology and Microbiology0.5%
  • Other1.2%

Topics

  • Brain Metastases and Treatment13.3%
  • Lung Cancer Research Studies9.4%
  • Lung Cancer Treatments and Mutations8.8%
  • Lung Cancer Diagnosis and Treatment7.7%
  • Glioma Diagnosis and Treatment7.3%
  • Advanced Radiotherapy Techniques5.1%
  • Other48.4%

Coauthors

All papers

Open in search
  1. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 798

  2. Response assessment criteria for brain metastases: proposal from the RANO group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 1,088

  3. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 1,270

  4. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 cited by 1,086

  5. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, Yi An, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Journal of Clinical Oncology 2020 cited by 467

  6. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 455

  7. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 548

  8. Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 1,420

  9. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

    Authors: , , , , , , , , , , , , , - The Lancet 2004 cited by 2,426

  10. Estimating Survival in Patients With Lung Cancer and Brain Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2016 cited by 658

  11. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 301

  12. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    Authors: , , , , , , , , , , - Journal of Thoracic Oncology 2012 cited by 677

  13. Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials

    Authors: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1997 cited by 2,556

  14. Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    Authors: , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2009 cited by 985

  15. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 100

  16. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 96

  17. A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database

    Authors: , , , , - International Journal of Radiation Oncology*Biology*Physics 2007 cited by 1,043

  18. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

    Authors: , , , , , , , , , , , , , - Practical Radiation Oncology 2012 cited by 590

  19. Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus

    Authors: , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2010 cited by 391

  20. Graded Prognostic Assessment (GPA) for Patients With Lung Cancer and Brain Metastases: Initial Report of the Small Cell Lung Cancer GPA and Update of the Non-Small Cell Lung Cancer GPA Including the Effect of Programmed Death Ligand 1 and Other Prognostic Factors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yi An, Veronica Chiang, Liang Zeng, Hany Soliman, Hesham Elhalawani, Daniel Cagney, Evan Thomas, Drexell H. Boggs, Manmeet S. Ahluwalia, Minesh P. Mehta - International Journal of Radiation Oncology*Biology*Physics 2022 cited by 120

  21. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases

    Authors: , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 1,095

  22. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases

    Authors: , , , , , , , , , , , - Journal of Clinical Oncology 2009 cited by 804

  23. Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 384

  24. The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

    Authors: , , , , , , , , , , , , , , , , , - Journal of Neuro-Oncology 2009 cited by 351